Keros Therapeutics Inc (KROS) — Capital Reinvestment Ratio
Keros Therapeutics Inc (KROS) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow ($3.25 Million) in capital expenditures ($132.00K). Check KROS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Keros Therapeutics Inc Capital Reinvestment Ratio (2018–2018)
This chart tracks Keros Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Keros Therapeutics Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Keros Therapeutics Inc (2018–2018)
Year-by-year Capital Reinvestment Ratio for Keros Therapeutics Inc from 2018 to 2018. See KROS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.03x | $7.04 Million | $217.00K | — |